In patients with stage III lung adenocarcinoma undergoing adjuvant chemotherapy, the proportion of CD8+ CD103+ tissue-resident memory T cells (TRM) in TLS significantly increased with the maturation of TLS, with a more favorable prognosis linked to mature TLS displaying the CD103+ TRM high phenotype (35). The gene discussed is ITGAE; the disease is lung adenocarcinoma.